Symbol="VACC"
AssetType="Common Stock"
Name="Vaccitech PLC ADR"
Description="Vaccitech plc, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new T-cell vaccines and immunotherapies for the treatment and prevention of infectious diseases and cancers. The company is headquartered in Oxford, United Kingdom."
CIK="1828185"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="THE SCHRODINGER BUILDING, HEATLEY ROAD, THE OXFORD SCIENCE PARK, OXFORD, GB"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="79809000"
EBITDA="-23452000"
PERatio="None"
PEGRatio="None"
BookValue="6.45"
DividendPerShare="0"
DividendYield="0"
EPS="-0.4"
RevenuePerShareTTM="1.2"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.0566"
ReturnOnEquityTTM="-0.0636"
RevenueTTM="30153000"
GrossProfitTTM="44703000"
DilutedEPSTTM="-0.4"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.969"
AnalystTargetPrice="12.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.311"
PriceToBookRatio="0.359"
EVToRevenue="1.506"
EVToEBITDA="-9.07"
Beta="0.136"
num_52WeekHigh="7.45"
num_52WeekLow="2"
num_50DayMovingAverage="2.291"
num_200DayMovingAverage="2.491"
SharesOutstanding="38369800"
DividendDate="None"
ExDividendDate="None"
symbol="VACC"
open="2.17"
high="2.21"
low="2.00"
price="2.08"
volume="51378.00"
latest_trading_day="2023-08-11"
previous_close="2.19"
change="-0.11"
change_percent="-5.0228%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="90"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="10"
Volume_recent_avg="37503"
Change_recent_avg="-0.03"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.28"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="10"
Aroon_momentum_negative="90"
image_negative_thumbnail_id_1="1087"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0120.jpeg"
image_negative_thumbnail_id_2="132"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0044.jpeg"
image_neutral_thumbnail_id_1="537"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_neutral_thumbnail_id_2="582"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_positive_thumbnail_id_1="1001"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0163.jpeg"
image_positive_thumbnail_id_2="661"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0047.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
